{"url_path":"/sec/alxo/8-k/2026-06-30/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-30","source_url":"https://www.sec.gov/Archives/edgar/data/1810182/0001193125-26-290447-index.html","accession_number":"0001193125-26-290447","cik":"0001810182","ticker":"ALXO","issuer_name":"ALX ONCOLOGY HOLDINGS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1810182/0001193125-26-290447-index.html","primary_entity_key":"0001810182","primary_entity_name":"ALX ONCOLOGY HOLDINGS INC"},"word_count":76,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits.\n\n \n\nExhibit\n\nNumber\n\n \n\nDescription\n\n \n\n \n\n \n\n99.1\n\n[Press Release dated June 30, 2026](alxo-ex99_1.htm)\n\n \n\n \n\n \n\n104\n\n \n\nCover Page Interactive Data File (formatted as Inline XBRL)\n\n \n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\nALX ONCOLOGY HOLDINGS INC.\n\n \n\n \n\n \n\n \n\nDate: June 30, 2026\n\nBy:\n\n/s/ Jason Lettmann\n\nJason Lettmann\n\nChief Executive Officer"}